In Memoriam: Melvin Greer (1929-2010)

Abstract

Get full access to this article

View all access options for this article.

References

Greer M. , Schotland M. Myasthenia gravis in the newborn. Pediatrics. 1960;26:101-108.

Greer M. , Fishman RA Effects of experimental obstructive hydrocephalus upon the cerebrum. Trans Am Neurol Assoc. 1961;86:23-27.

Rowland LP , Greer M. Toxoplasmic polymyositis. Neurology. 1961;11:367-370.

Greer M. , Schotland D. Abnormal hemoglobin as a cause of neurologic disease. Neurology . 1962;12:114-123.

Williams CM , Greer M. Biochemical diagnosis of neuroblastoma. JAMA. 1963;183:884.

Greer M. , Williams CM The sympathetic neurohormones in pheochromocytoma, neuroblastoma and dysautonomia . Trans Am Neurol Assoc. 1963;88:223-224.

Greer M. , Williams CM Dopamine metabolism in Parkinson’s disease. Neurology . 1963;13:73-76.

Fishman RA , Greer M. Experimental obstructive hydrocephalus: changes in the cerebrum. Arch Neurol. 1963;8:156-161.

Williams CM , Dorin GE , Greer M. Determination of beta-phenyllactic acid by gas chromatography. Anal Biochem. 1963;6:468-471.

10.

Schwartz GC , Greer M. Immunologic tolerance to neural tissues in the newborn. Clin Res. 1964;12:36.

11.

Bowers DE , Greer M. Cerebellar agenesis in siblings. Neurology. 1964;14:273.

12.

Greer M. Benign intracranial hypertension: IV. Menarche. Neurology . 1964;14:569-573.

13.

Greer M. Benign intracranial hypertension: V. Menstrual dysfunction. Neurology. 1964;14:668-673.

14.

Greer M. Hartnup’s syndrome. Trans Am Neurol Assoc. 1965;90:53-59.

15.

Williams CM , Greer M. Gas chromatography of urinary vanilmandelic acid in pheochromocytoma. Clin Chim Acta. 1965;11:495-500.

16.

Greer M. , Anton AH , Williams CM , Echevarria RA Tumors of neural crest origin: biochemical and pathological correlation. Arch Neurol. 1965;13:139-148.

17.

Shanklin DR , Greer M. Clinicopathological conference. University of Florida College of Medicine . J Fla Med Assoc. 1965;52:722-726.

18.

Bondurant RE , Greer M. , Williams CM Gas chromatography of urinary homogentisic acid. Anal Biochem . 1966;15:364-366.

19.

Anton AH , Greer M. The effect of reserpine on catecholamine metabolism and behavior in retarded children. Clin Pharm Ther. 1966;7:727-739.

20.

Quick DT , Greer M. Pancreatic dysfunction in patients with amyotrophic lateral sclerosis. Neurology. 1967;17:112-116.

21.

Anton AH , Greer M. , Sayre DF , Williams CM Dihydroxyphenylalanine secretion in a malignant pheochromocytoma. Am J Med. 1967;42:469-475.

22.

Agee OF , Greer M. Anomalous cephalic venous drainage in association with aneurysm of the great vein of Galen. Radiology. 1967;88:725-729.

23.

Greer M. Benign intracranial hypertension (pseudotumor cerebri). Pediatr Clin North Am. 1967;4:819-830.

24.

Freeman FR , Parker RL Jr , Greer M. Unusual neurotoxicity of kanamycin. JAMA. 1967;200:410-411.

25.

Greer M. , Williams CM Gas chromatographic methods for the determination of melatonin and 6-hydroxymelatonin . Clinica Chimica Acta. 1967;15:165-167.

26.

Greer M. Management of benign intracranial hypertension (pseudotumor cerebri). Clin Neurosurg. 1968;15:161-174.

27.

Greer M. Anesthesia and seizures. Int Anesthesiol Clin. 1968;6:351-359.

28.

Greer M. , Sprinkle TJ , Williams WM Determination of urinary 3-methoxytyramine, normetanephrine and metanephrine in pheochromocytoma and neuroblastoma by gas chromatography. Clinica Chimica Acta. 1968;21:247-254.

29.

Williams CM , Porter AH , Greer M. , Scott KN , Sweeley CC Identification of urinary N-(phenylacetyl)-L-glutamic acid in neuroblastoma . Biochem Med. 1969;3:164-176.

30.

Greer M. , Anton AH , Williams CM Failure of enzyme inhibition therapy for malignant melanoma. Trans Am Neurol Assoc. 1969;94:273-275.

31.

Williams CM , Porter AH , Greer M. Mass Spectrometry of Biologically Important Aromatic Acids. Gainesville, FL: University of Florida Press; 1969.

32.

Sprinkle TJ , Porter AH , Greer M. , Williams CM A simple method for determination of methylmalonic acid by gas chromatography . Clinica Chimica Acta. 1969;24:476-478.

33.

Greer M. Managing a child’s first convulsion. Postgrad Med. 1969;46:109-112.

34.

Sprinkle TJ , Porter AH , Greer M. , Williams CM An improved method for the determination of homovanillic acid and vanilmandelic acid by gas chromatography. Clinica Chimica Acta. 1969;25:409-411.

35.

Anton AH , Greer M. Dextroamphetamine, catecholamines, and behavior: the effect of dextroamphetamine in retarded children. Arch Neurol. 1969;21:248-252.

36.

Greer M. , Anton AH Cerebral catecholamine concentration after L-dopa therapy in Parkinson’s disease. Trans Am Neurol Assoc. 1970;95:247-248.

37.

Williams CM , Greer M. IV: Estimation by gas chromatography of urinary homovanillic acid and vanilmandelic acid in neuroblastoma. Methods Med Res. 1970 ;12:106-114.

38.

Rennert OM , Greer M. Hereditary fructosemia. Neurology. 1970;20:421-425.

39.

Greer M. L-Dopa therapy in Parkinson’s disease. J Fla Med Assoc . 1970;57:23-27.

40.

Bercaw BL , Greer M. Transport of intrathecal 131-I risa in benign intracranial hypertension. Neurology. 1970;20:787-790.

41.

Schmidt RP , Greer M. Levodopa and relief of Parkinsonian symptoms. Arq Neuropsiquiatr . 1971;2:21-25.

42.

Greer M. , Collins GH , Anton AH Cerebral catecholamines after levodopa therapy. Arch Neurol . 1971;25:461-467.

43.

Vroom FQ , Greer M. Mercury vapour intoxication. Brain. 1972;95:305-318.

44.

Foltz RL , Couch MW , Greer M. , Scott KN , Williams CM Chemical ionization mass spectrometry in the identification of drug metabolites . Biochem Med. 1972;6:294-298.

45.

Greer M. On coma. Emerg Med. 1972;4:139-146.

46.

Couch MW , Greer M. , Scoot KN , Williams CM Low molecular weight constituents of cerebrospinal fluid: N-benzoylglycine (hippuric acid). J Neurochem. 1973;20:893-896.

47.

Wroe M. , Greer M. Parkinson’s disease and physical therapy management. Phys Ther. 1973;53:849-855.

48.

Greer M. Management of the patient with acute stroke. Geriatrics. 1973;28:48-53.

49.

Couch MW , Greer M. , Williams CM Determination of primidone and its metabolites in biological fluids by gas chromatography. J Chromatogr. 1973;87:559-561.

50.

Greer M. Acute stroke. Med Surg. 1974;14:15-19.

51.

Greer M. Pain: focus on headache. Med Opin. 1975;4:12-15.

52.

Heilman KM , Bowers D. , Watson RT , Greer M. A reaction time study of hypokinesia in Parkinson’s disease. Trans Am Neurol Assoc. 1975;100:199-200.

53.

Greer M. Tracking down the cause of dizziness. Geriatrics. 1975;30:133-136.

54.

Heilman KM , Bowers D. , Watson RT , Greer M. Reaction times in Parkinson disease. Arch Neurol. 1976;33:139-140.

55.

Greer M. How to achieve maximum benefit for the patient with Parkinson’s disease . Geriatrics. 1976;31:89-96.

56.

Yasuda N. , Greer MA Distribution of corticotropin releasing factor(s) activity in neural and extraneural tissues of the rat. Endocrinology. 1976;99:944-948.

57.

Jarrell MA , Greer M. , Maren TH The effect of acidosis in hypokalemic periodic paralysis. Arch Neurol. 1976;33:791-793.

58.

Greer M. Uncommon causes of stroke: Part 1. Diseases of the vessel wall. Geriatrics. 1977;32:28-32, 39-41.

59.

Greer M. Clinical neurology in the aging patient. Geriatrics. 1977;32:27.

60.

Heilman KM , Watson RT , Greer M. Handbook for Differential Diagnosis of Neurologic Signs and Symptoms. New York, NY: Appleton-Century-Crofts; 1977.

61.

Greer M. Uncommon causes of stroke: Part 2. Changes in blood constituents and hemodynamic factors. Geriatrics. 1978;33: 51-56.

62.

Greer M. Drug therapy for Parkinson’s disease. South Med J. 1978;71:448-452.

63.

Enoch JM , Campos EC , Greer M. , Trobe J. Measurement of visual resolution at high luminance levels in patients with possible demyelinating disease. Int Ophthalmol. 1979;1:99-104.

64.

Greer M. Current concepts in managing TIAs and stroke. Geriatrics. 1979;34:53-59.

65.

Greer M. Emergency evaluation of head injuries in the elderly. Geriatrics . 1979;34:73-84.

66.

Greer M. Pre-term baby: an inheritance of a different kind. Nurs Mirror . 1979;149:42-44.

67.

Andriola M. , Greer M. Childhood seizures. Continuing Educ Fam Physician. 1980;12:50-58.

68.

Greer M.

How serious is dizziness?

Geriatrics. 1981 ;36(1):34-42. Greer M. Dementia: a major disease of aging. Geriatrics. 1982;37:101-103, 107-111, 114.

69.

Greer M. Strategies for reducing stroke frequency. Geriatrics. 1982;37:36-42.

70.

Greer M. , Roubik JB A time to hope and a time to die. RN. 1983 ;46:56-60.

71.

Greer M. Syncope: a predisposition of the elderly. Geriatrics. 1983;28:27.

72.

Armstrong D. , Sawson W. , Greer M. , Ballinger W. , Ongley J. , Modgle D. Evaluation of visual function in Kufs disease. Invest. Ophthalmol Vis Sci. 1983;24(suppl):289.

73.

Greer M. , Dimick S. , Burns S. Heart rate and blood pressure response to several methods of strength training . Phys Ther. 1984;64:179-183.

74.

LeVine E. , Greer M. Long-term effectiveness of the Adolescent Learning Center: a challenge to the concept of least restrictive environment. Adolescence . 1984l;19:521-526.

75.

Hunter S. , Ballinger WE Jr , Greer M. Nitrogen inhalation in the human. Acta Neuropathol. 1985;68:115-121.

76.

Greer M. Recent developments in the treatment of Parkinson’s disease. Geriatrics. 1985;40:34-38, 41.

77.

Dawson WW , Armstrong D. , Greer M. , Maida TM , Samuelson DA Disease-specific electrophysiological findings in adult ceroidlipofuscinosis (Kufs disease). Doc Ophthalmol. 1985;60: 163-171.

78.

Greer M. Carrier drugs. Presidential address American Academy of Neurology, 1987. Neurology. 1988;38:628-632.

79.

Greer M. Perinatal perspective: the NPA forum. Access to care, part 3. J Perinatol. 1991;11:300-301.

80.

Seales D. , Greer M. Acute hemorrhagic leukoencephalitis: a successful recovery. Arch Neurol. 1991;48:1086-1088.

81.

Greer M. Acute viral encephalitis. Intern Med. 1989 ;10:91-98.

82.

Greer M. Practical migraine treatment and prevention. Intern Med. 1996;17:25-29.

83.

Young MS , Triggs WJ , Bowers D. , Greer M. , Friedman WA Stereotactic pallidotomy lengthens the transcortical magnetic cortical stimulation silent period in Parkinson’s disease. Neurology. 1997;49:1278-1283.

84.

Hoerger TJ , Bala MV , Rowland C. , Greer M. , Chrischilles EA , Holloway RG Cost effectiveness of pramipexole in Parkinson’s disease in the US. Pharmacoeconomics. 1998;14:541-557.

85.

Greer M. , Monteban H. A review of quality of life in Alzheimer’s disease: Parts 1 and 2: Issues in assessing disease impact and drug effects. Pharmacoeconomics . 1999;15:641-644.

86.

Schulz GM , Peterson T. , Sapienza CM , Greer M. , Friedman W. Voice and speech characteristics of persons with Parkinson’s disease pre-and post-pallidotomy surgery: preliminary findings. J Speech Lang Hear Res. 1999;42:1176-1194.

87.

Schulz GM , Greer M. , Friedman W. Changes in vocal intensity in Parkinson’s disease following pallidotomy surgery. J Voice. 2000;14:589-606.

88.

Crucian GP , Huang L. , Barrett AM , et al. Emotional conversations in Parkinson’s disease. Neurology. 2001;56:159-165.

89.

Crucian GP , Barrett AM , Burks DW , et al. Mental object rotation in Parkinson’s disease. J Int Neuropsychol Soc. 2003;9: 1078-1087.

90.

Optic Neuritis Study Group. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis. Arch Opthalmol. 2003;121:944-949.

91.

Stacpoole PW , Kerr DS , Barnes C. , et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics. 2006;117:1519-1531.

92.

Gaylord M. , Greer M. , Botti J. Improving perinatal health: a novel approach to improve community and adult health. J Perinatol. 2008;28:91-96.

93.

Optic Neuritis Study Group. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology. 2008;115:1079-1082.

94.

Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up . Arch Neurol. 2008;65:727-732.

95.

Greer M. Benign intracranial hypertension: I. Mastoiditis and lateral sinus obstruction . Neurology. 1962;12:472-476.

96.

Greer M. Benign intracranial hypertension: II. Following corticosteroid therapy. Neurology. 1963;13:439-441.

97.

Greer M. , Berk MS Lateral sinus obstruction and mastoiditis. Pediatrics. 1963;31:840-844.

98.

Greer M. Benign intracranial hypertension: III. Pregnancy. Neurology . 1963;13:670-672.

99.

Greer M. Benign intracranial hypertension: VI. Obesity. Neurology. 1965;15:382-388.

100.

Williams CM , Greer M. Diagnosis of neuroblastoma by quantitative gas chromatographic analysis of urinary homovanillic and vanilmandelic acid. Clin Chim Acta . 1962;7:880-883.

101.

Williams CM , Greer M. Homovanillic acid and vanilmandelic acid in diagnosis of neuroblastoma. JAMA. 1963;183:836-840.

102.

Greer M. , Williams CM Diagnosis of homocystinuria by gas chromatography. Anal Biochem . 1967;19:40-45.

103.

Greer M. , Williams CM Diagnosis of branched-chain ketonuria (maple syrup urine disease) by gas chromatography . Biochem Med. 1967;1:37-91.

104.

Greer M. , Hutcheson CE , Williams CM Abnormal urinary excretion of p-hydroxyphenyllactic acid in Wilms’ tumor . Clin Chim Acta. 1968;22:460-462.

105.

Sprinkle T. , Greer M. , Williams CM Detection of argininosuccinic aciduria by gas chromatography. Clin Chim Acta. 1969;23: 27-31.

106.

Julius R. , Buehler B. , Aylsworth A. , Petery LS , Rennert O. , Greer M. Diagnostic techniques in metachromatic leukodystrophy. Neurology . 1971;21:15-18.

107.

Stacpoole PW , Bunch ST , Neiberger RE , et al. The importance of cerebrospinal fluid lactate in the evaluation of congenital lactic acidosis. J Pediatr. 1999;134:99-102.